Coping and Perception of Prognosis in Patients With Indolent Non-Hodgkin’s Lymphoma
The Oncologist · 2024
DOI: 10.1093/oncolo/oyad295 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2024. Verfasst von Richard A Newcomb und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Lymphoma, Non-Hodgkin, Adaptation, Psychological, Quality of Life. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Background
Indolent non-Hodgkin’s lymphomas (iNHL) are a heterogenous group of mostly incurable diseases with prolonged illness courses and prognostic uncertainty. Yet, studies evaluating coping and perception of prognosis are limited.
Methods
We conducted a cross-sectional study of adults newly diagnosed with iNHL in the past 3 months at a single academic center. We assessed quality of life (QOL: Functional Assessment of Cancer Therapy—General), psychological symptoms (Hospital Anxiety and Depression Scale), coping (Brief-COPE), and perception of prognosis (Prognosis Awareness Impact Scale).
Results
We enrolled 70.6% (48/68) of eligible patients. Patients had older age (mean = 66.9,sd = 10.5), were female (60.4%), predominantly identified as White (85.4%), and had at least received a college degree (75%). Chronic lymphocytic leukemia (39.6%) and follicular lymphoma (33.3%) were the most common diagnoses. Overall, 27.1% and 14.6% of patients reported clinically significant anxiety and PTSD symptoms, respectively. Patients highly utilized acceptance (56.2%), seeking emotional support (47.9%), and denial (47.9%) as coping strategies at diagnosis. While 66.7% of patients recalled their oncologist assessment of illness as incurable, only 35.4% reported that the illness is unlikely to be cured. Overall, 45.8% indicated that they were worried about prognosis and 31.2% reported perseverating on their prognosis. Higher emotional coping with prognosis was associated with fewer anxiety (B = −0.6, SE = 0.2, P < .001), depression (B = −0.3, SE = .1, P = .005), and PTSD (B = −1.3, SE = 0.4, P < .001) symptoms and better QOL (B = 1.7, SE = 0.4, P < .001).
Discussion
Patients with iNHL report substantial psychological distress, a diversity of coping strategies, and complex cognitive understanding of their prognosis. Interventions, which address prognostic uncertainty and promote positive emotional coping with prognosis, may ameliorate psychological distress in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
- Duke University School of Medicine, Durham, NC, USA.
- Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, USA.
ORCID-Profile: Richard A Newcomb, Areej El-Jawahri
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Newcomb, R. A., Johnson, P. C., Yang, D., Holmbeck, K., Choe, J., Nabily, A., Lark, P., Dhawale, T., Amonoo, H. L., & El-Jawahri, A. (2024). Coping and Perception of Prognosis in Patients With Indolent Non-Hodgkin’s Lymphoma. The Oncologist. https://doi.org/10.1093/oncolo/oyad295
Vancouver
Newcomb RA, Johnson PC, Yang D, Holmbeck K, Choe J, Nabily A, et al. Coping and Perception of Prognosis in Patients With Indolent Non-Hodgkin’s Lymphoma. The Oncologist. 2024. doi:10.1093/oncolo/oyad295
BibTeX
@article{Newcomb2024,
author = {Newcomb, Richard A and Johnson, P Connor and Yang, Daniel and Holmbeck, Katherine and Choe, Joanna and Nabily, Anisa and Lark, Porsha and Dhawale, Tejaswini and Amonoo, Hermioni L and El-Jawahri, Areej},
title = {Coping and Perception of Prognosis in Patients With Indolent Non-Hodgkin’s Lymphoma},
journal = {The Oncologist},
year = {2024},
doi = {10.1093/oncolo/oyad295}
}
EUVIMED